title: A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B.
authors.affiliation: Department of Infectious Diseases, The First Affiliated Hospital of Kunming Medical College, 153# Xi Chang Road, Kunming 650032, Yunnan Province, China.
authors.forename: J
authors.initials: J
authors.lastname: You
authors.forename: L
authors.initials: L
authors.lastname: Zhuang
authors.forename: B Z
authors.initials: BZ
authors.lastname: Tang
authors.forename: W B
authors.initials: WB
authors.lastname: Yang
authors.forename: S Y
authors.initials: SY
authors.lastname: Ding
authors.forename: W
authors.initials: W
authors.lastname: Li
authors.forename: R X
authors.initials: RX
authors.lastname: Wu
authors.forename: H L
authors.initials: HL
authors.lastname: Zhang
authors.forename: Y M
authors.initials: YM
authors.lastname: Zhang
authors.forename: S M
authors.initials: SM
authors.lastname: Yan
authors.forename: L
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D000077596:Thymalfasin; D013947:Thymosin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D016898:Interferon-alpha; D013947:Thymosin; D000077596:Thymalfasin